| Pubmed ID |
Author | Year | Title |
28042411 |
Kahyaoglu S | 2017 | Clomiphene Citrate Treatment Cycle Outcomes of Polycystic Ovary Syndrome Patients Based on Basal High Sensitive C-Reactive Protein Levels: A Cross-Sectional Study. |
28042549 |
Foroozanfard F | 2017 | Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome. |
28043072 |
Guo Z | 2017 | Association of serum organochlorine pesticides concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population. |
28045919 |
Lindheim L | 2017 | Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. |
28049245 |
Shin JJ | 2017 | Major Disease Prevalence and Menstrual Characteristics in Infertile Female Korean Smokers. |
28051267 |
Tan J | 2016 | Reduced expression of SCF in serum and follicle from patients with polycystic ovary syndrome. |
28051885 |
Deng H | 2017 | Elevated serum interferon ?-inducible protein-10 in women with polycystic ovary syndrome. |
28051891 |
Yin D | 2017 | The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome. |
28058854 |
Patel R | 2017 | Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. |
28060790 |
Sun X | 2017 | Family-Based Association Study of rs17300539 and rs12495941 Polymorphism in Adiponectin Gene and Polycystic Ovary Syndrome in a Chinese Population. |
28068351 |
Pau CT | 2017 | Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome. |
28069449 |
Graham EJ | 2017 | A model of ovulatory regulation examining the effects of insulin-mediated testosterone production on ovulatory function. |
28069897 |
Armeni AK | 2017 | Impact of estrogen receptor ? gene and oxytocin receptor gene polymorphisms on female sexuality. |
28070371 |
Williams S | 2015 | 'Everything's from the inside out with PCOS': Exploring women's experiences of living with polycystic ovary syndrome and co-morbidities through Skype? interviews. |
28070801 |
Noroozzadeh M | 2017 | A Comparison of Sexual Function in Women with Polycystic Ovary Syndrome (PCOS) Whose Mothers Had PCOS During Their Pregnancy Period with Those Without PCOS. |
28071011 |
Swora-Cwynar E | 2016 | The effects of a low-calorie diet or an isocaloric diet combined with metformin on sex hormones In obese women of child-bearing age. |
28079802 |
Jiang LL | 2017 | Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome. |
28081274 |
Wu JB | 2016 | Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk. |
28081337 |
Akda? Cirik D | 2016 | Do anxiety and depression statuses differ in differentpolycystic ovary syndrome phenotypes? |
28082237 |
Niu Z | 2017 | Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization. |
28082338 |
McLuskie I | 2017 | New diagnosis of polycystic ovary syndrome. |
28082426 |
Selen Alpergin ES | 2017 | Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine. |
28083040 |
Chen Z | 2016 | Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. |
28088464 |
Carvalho LM | 2017 | Microparticles: Inflammatory and haemostatic biomarkers in Polycystic Ovary Syndrome. |
28088992 |
Ranasinghe GC | 2017 | Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients. |
28089571 |
Pinola P | 2017 | Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life. |
28090348 |
Stener-Victorin E | 2016 | Changes in HbA<sub>1c</sub> and circulating and adipose tissue androgen levels in overweight-obese women with polycystic ovary syndrome in response to electroacupuncture. |
28090459 |
Hestiantoro A | 2016 | Anti-M?llerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate. |
28091905 |
Kolesnikova LI | 2017 | Activity of LPO Processes in Women with Polycystic Ovarian Syndrome and Infertility. |
28092404 |
Tagliaferri V | 2017 | Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study. |
28093231 |
Pournaderi PS | 2017 | The effects of 6-Gingerol on reproductive improvement, liver functioning and Cyclooxygenase-2 gene expression in estradiol valerate - Induced polycystic ovary syndrome in Wistar rats. |
28096785 |
Mansour A | 2016 | Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome. |
28099123 |
Alexiou E | 2017 | Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index. |
28099715 |
Macruz CF | 2017 | Assessment of the body composition of patients with polycystic ovary syndrome using dual-energy X-ray absorptiometry. |
28102491 |
Muscogiuri G | 2017 | Shedding new light on female fertility: The role of vitamin D. |
28104244 |
Lee I | 2017 | Increased risk of disordered eating in?polycystic ovary syndrome. |
28104402 |
Engmann L | 2017 | Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype. |
28107851 |
Fang F | 2017 | Effect of vitamin D supplementation on polycystic ovary syndrome: A?systematic review and meta-analysis of randomized controlled trials. |
28108363 |
Mudrovcic N | 2017 | Endothelial maintenance in health and disease: Importance of sex differences. |
28109841 |
Patel S | 2017 | Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review. |
28116888 |
Jin SG | 2017 | The fertilization potential of oocytes may be compromised in women with polycystic ovary syndrome. |
28118681 |
Bordewijk EM | 2017 | Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome. |
28119323 |
Nylander M | 2017 | Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential. |
28119448 |
Wang R | 2017 | The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? |
28122439 |
Liu AL | 2016 | New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer |
28123936 |
Stechemesser L | 2017 | Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. |
28125989 |
Liao Y | 2017 | An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients. |
28127831 |
Reis GV | 2017 | Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review. |
28128085 |
Przepiera-B?dzak H | 2016 | Antiphospholipid Syndrome with Anti?2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome. |
28132572 |
Cui N | 2017 | Decreased expression of fatty acid amide hydrolase in women with polycystic ovary syndrome. |
28135285 |
Ujvari D | 2017 | Dysregulation of In Vitro Decidualization of Human Endometrial Stromal Cells by Insulin via Transcriptional Inhibition of Forkhead Box Protein O1. |
28139236 |
Roesner S | 2017 | Time-lapse imaging reveals differences in growth dynamics of embryos after in?vitro maturation compared with conventional stimulation. |
28139507 |
Tan J | 2017 | Increased Risk of Psychiatric Disorders in Women with Polycystic Ovary Syndrome in Southwest China. |
28139522 |
Zhou F | 2017 | Ovarian Fibrosis: A Phenomenon of Concern. |
28139539 |
Reddy BM | 2016 | Association of type 2 diabetes mellitus genes in polycystic ovary syndrome aetiology among women from southern India. |
28139558 |
Durmanova AK | 2016 | [Anti-M?llerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome]. |
28141959 |
Celik F | 2017 | Plasma L-carnitine levels of obese and non-obese polycystic ovary syndrome patients. |
28142296 |
Ahmadi S | 2017 | Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. |
28143456 |
Jensterle M | 2017 | Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial. |
28143834 |
Wang R | 2017 | Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. |
28145863 |
Gu HF | 2016 | The association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome. |
28146139 |
Papadakis G | 2017 | Is cardiovascular risk in women with PCOS a real risk? Current insights. |
28149157 |
Yonggang H | 2017 | Effects of human chorionic gonadotropin combined with clomiphene on Serum E<sub>2</sub>, FSH, LH and PRL levels in patients with polycystic ovarian syndrome. |
28152641 |
Kulkarni M | 2017 | A review of paediatric and adolescent gynaecology services in a tertiary outpatient clinic. |
28156151 |
Jellinger PS | 2017 | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY<sub>Complete Appendix to Guidelines available at http://journals.aace.com</sub>. |
28157253 |
Ambroziak U | 2017 | Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients. |
28157691 |
Figurov? J | 2017 | The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome. |
28159846 |
Lai L | 2017 | Standardised versus individualised multiherb Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility and pilot study in the UK. |
28160242 |
Mazloomi S | 2017 | Serum Zinc and Adiponectin Levels in Patients with Polycystic Ovary Syndrome, Adjusted for Anthropometric, Biochemical, Dietary Intake, and Physical Activity Measures. |
28165551 |
Kowalczyk K | 2017 | Thyroid disorders in polycystic ovary syndrome. |
28168653 |
Freis A | 2017 | Effects of a hyperandrogenaemic state on the proliferation and decidualization potential in human endometrial stromal cells. |
28168992 |
?zdemir O | 2016 | The relationship between atypical depression and ins?lin resistance in patients with polycystic ovary syndrome and major depression. |
28175322 |
Poromaa IS | 2017 | Should we individualize lipid profiling in women with polycystic ovary syndrome? |
28176325 |
Shafiee MN | 2017 | Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer. |
28177124 |
Dantas WS | 2017 | Acute exercise elicits differential expression of insulin resistance genes in the skeletal muscle of patients with polycystic ovary syndrome. |
28178574 |
Uysal G | 2017 | Is acne a sign of androgen excess disorder or not? |
28182154 |
Karaca Ad?yeke S | 2017 | Anterior Segment Findings in Women with Polycystic Ovary Syndrome. |
28182362 |
Li N | 2017 | Upregulation of FoxO 1 Signaling Mediates the Proinflammatory Cytokine Upregulation in the Macrophage from Polycystic Ovary Syndrome Patients. |
28183310 |
Paix?o L | 2017 | Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review. |
28187771 |
Homer MV | 2017 | The effect of estradiol on granulosa cell responses to FSH in women with polycystic ovary syndrome. |
28190890 |
Stassek J | 2017 | C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal - Evidence for an Increased Insulin Clearance in PCOS Patients? |
28193283 |
Xiong W | 2017 | Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population. |
28195137 |
Peng Y | 2017 | ERBB4 Confers Risk for Polycystic Ovary Syndrome in Han Chinese. |
28199736 |
Dokras A | 2017 | Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome. |
28201826 |
Mario FM | 2017 | Adiposity Indexes as Phenotype-Specific Markers of Preclinical Metabolic Alterations and Cardiovascular Risk in Polycystic Ovary Syndrome: A Cross-Sectional Study. |
28203719 |
Roberts JS | 2017 | High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model?. |
28208942 |
Shayan A | 2016 | Comparing the Effects of Agnugol and Metformin on Oligomenorrhea in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial. |
28211992 |
Speer AL | 2017 | Thirty-day outcomes for children and adolescents undergoing laparoscopic sleeve gastrectomy at a free-standing children's hospital. |
28212475 |
Carranza-Lira S | 2017 | [Frequency of increased thyrotropin in women with hyperprolactinemia]. |
28216918 |
Verma S | 2016 | Spontaneous conception in 40-year-old infertile woman with polycystic ovaries after complete reversal of endometrial intraepithelial neoplasia: A case report with review of literature. |
28222635 |
Qu Q | 2017 | Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome. |
28222828 |
Jeanes YM | 2017 | Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. |
28224431 |
Zhang F | 2017 | Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome. |
28228317 |
Elkind-Hirsch KE | 2017 | Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study. |
28228318 |
Daan NM | 2017 | Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome. |
28234803 |
Turcu AF | 2017 | Clinical significance of 11-oxygenated androgens. |
28235206 |
Nasri K | 2017 | The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome. |
28235465 |
Tal R | 2017 | Ovarian reserve testing: a user's guide. |
28238455 |
Metzler VM | 2017 | Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development. |
28238496 |
Liang P | 2017 | Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome. |
Showing 14,101–14,200 of 14,368